Related references
Note: Only part of the references are listed.Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review
Ala-Eddine Deghmane et al.
INFECTIOUS DISEASES (2022)
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England
Shamez N. Ladhani et al.
CLINICAL INFECTIOUS DISEASES (2021)
Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
Josephine Mauskopf et al.
VALUE IN HEALTH (2021)
Implementation Experience With Meningococcal Serogroup B Vaccines in the United States Impact of a Nonroutine Recommendation
Jaime Fergie et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease
Ekkehard Beck et al.
VALUE IN HEALTH (2021)
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
Muhamed-Kheir Taha et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
A review of the epidemiology of invasive meningococcal disease and vaccination strategies in North Africa
Muhamed-Kheir Taha et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
The recommended lifetime immunization schedule from the board of vaccination calendar for life in Italy: A continuing example of impact on public health policies
P. Bonanni et al.
VACCINE (2021)
Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States
Kunal Saxena et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
A beautiful idea: how COVAX has fallen short
Ann Danaiya Usher
LANCET (2021)
Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020
Marion Taine et al.
FRONTIERS IN PEDIATRICS (2021)
Australian Meningococcal Surveillance Programme Annual Report, 2020
Monica M. Lahra et al.
COMMUNICABLE DISEASES INTELLIGENCE (2021)
Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations
Liping Huang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine
Shannon L. Harris et al.
NPJ VACCINES (2020)
Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020
Helen McDonald et al.
EUROSURVEILLANCE (2020)
Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
Amit Srivastava et al.
BMC PUBLIC HEALTH (2020)
Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits
Andrew Stawasz et al.
FRONTIERS IN PUBLIC HEALTH (2020)
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination
Sydel R. Parikh et al.
JOURNAL OF INFECTION (2020)
Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative
Aye Mya Min Aye et al.
JOURNAL OF INFECTION (2020)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019
Laurie D. Elam-Evans et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018)
Chiara Azzari et al.
VACCINES (2020)
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
Isabelle Leduc et al.
PLOS PATHOGENS (2020)
Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
Muhamed-Kheir Taha et al.
BMC RESEARCH NOTES (2020)
Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence
Sara Boccalini et al.
MICROORGANISMS (2020)
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates
Alessia Biolchi et al.
VACCINE (2020)
Economic evaluation of meningococcal vaccines: considerations for the future
Hannah Christensen et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2020)
Meningococcal vaccination in primary care amongst adolescents in North West England: an ecological study investigating associations with general practice characteristics
Sarah Blagden et al.
JOURNAL OF PUBLIC HEALTH (2019)
Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016
Nadav Topaz et al.
EBIOMEDICINE (2019)
Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017
Manuel Krone et al.
EUROSURVEILLANCE (2019)
Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis
Bing Wang et al.
VACCINE (2019)
Did school characteristics affect the uptake of meningococcal quadrivalent vaccine in Greater Manchester, United Kingdom?
R. Fletcher et al.
PUBLIC HEALTH (2019)
What school-level and area-level factors influenced HPV and MenACWY vaccine coverage in England in 2016/2017? An ecological study
Karen Tiley et al.
BMJ OPEN (2019)
Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile
R. Villena et al.
VACCINE (2019)
PIN43 LIFECYCLE-MODEL-BASED ECONOMIC EVALUATION OF INFANT MENINGITIS B VACCINATION IN THE UK
J. Sevilla et al.
VALUE IN HEALTH (2019)
Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016
Susan Meiring et al.
CLINICAL INFECTIOUS DISEASES (2019)
Meningococcal serogroups and surveillance: a systematic review and survey
Meagan E. Peterson et al.
JOURNAL OF GLOBAL HEALTH (2019)
Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016
D. Bennett et al.
EPIDEMIOLOGY AND INFECTION (2019)
Study of the Immune Response in the Elderly: Is It Necessary to Develop a Vaccine against Neisseria meningitidis for the Aged?
Gabriela Trzewikoswki de Lima et al.
JOURNAL OF AGING RESEARCH (2019)
Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI)
Junhong Li et al.
JOURNAL OF INFECTION (2018)
Association of Health Insurance Status and Vaccination Coverage among Adolescents 13-17 Years of Age
Peng-jun Lu et al.
JOURNAL OF PEDIATRICS (2018)
Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges
Mustapha M. Mustapha et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Adoption of Serogroup B Meningococcal Vaccine Recommendations
Allison Kempe et al.
PEDIATRICS (2018)
Strength and Clarity of Vaccine Recommendations Influence Providers' Practice
Michael T. Brady
PEDIATRICS (2018)
The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci
Shannon L. Harris et al.
VACCINE (2018)
Environmental, economic and socio-cultural risk factors of recurrent seasonal epidemics of cerebrospinal meningitis in Kebbi state, northwestern Nigeria: a qualitative approach
Semeeh A. Omoleke et al.
BMC PUBLIC HEALTH (2018)
2460. Factors Associated With Uptake of Meningococcus B Vaccination After an ACIP Category B Recommendation
Emily Watkins et al.
Open Forum Infectious Diseases (2018)
Equity of primary care service delivery for low income sicker adultsacross 10 OECD countries
Simone Dahrouge et al.
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2018)
Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015
I. Parent du Chatelet et al.
JOURNAL OF INFECTION (2017)
Population health in an era of rising income inequality: USA, 1980-2015
Jacob Bor et al.
LANCET (2017)
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2017)
Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil
Ana Lucia Andrade et al.
VACCINE (2017)
Changing epidemiology of invasive meningococcal disease in Australia 1994-2016
Helen V. Smith et al.
MICROBIOLOGY AUSTRALIA (2017)
Clonal Expansion of New Penicillin-Resistant Clade of Neisseria meningitidis Serogroup W Clonal Complex 11, Australia
Shakeel Mowlaboccus et al.
EMERGING INFECTIOUS DISEASES (2017)
Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016
Helen Campbell et al.
EMERGING INFECTIOUS DISEASES (2017)
Enter B and W: two new meningococcal vaccine programmes launched
Shamez N. Ladhani et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2016)
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero (R)) against meningococcal B disease: A cost-effectiveness analysis
Roberto Gasparini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Burden of Neisseria meningitidis infections in China: a systematic review and meta-analysis
Yaowen Zhang et al.
JOURNAL OF GLOBAL HEALTH (2016)
Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015
Cecilia B. Kretz et al.
EMERGING INFECTIOUS DISEASES (2016)
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
Sanjay Jayasinghe et al.
VACCINE (2015)
Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013
Michael Broeker et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales
Shamez N. Ladhani et al.
CLINICAL INFECTIOUS DISEASES (2015)
Barriers to the vaccination of children and adolescents and possible solutions
S. Esposito et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
Miguel O'Ryan et al.
DRUGS (2014)
Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data
Merijn W. Bijlsma et al.
LANCET INFECTIOUS DISEASES (2014)
The missing link: Family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines
Kathryn A. Taylor et al.
VACCINE (2014)
Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification
M. Garrido-Estepa et al.
VACCINE (2014)
Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
Hannah Christensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
The price of prevention: what now for immunisation against meningococcus B?
Richard Moxon et al.
LANCET (2013)
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study
Russell M. Viner et al.
LANCET NEUROLOGY (2012)
Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine
Dominique A. Caugant et al.
PLOS ONE (2012)
Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine
F. Marc LaForce et al.
HEALTH AFFAIRS (2011)
Meningococcal Disease in Children in Merseyside, England: A 31 Year Descriptive Study
Michelle C. Stanton et al.
PLOS ONE (2011)
The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease
Lee H. Harrison et al.
VACCINE (2011)
Meningococcal C conjugate vaccine: The experience in England and Wales
Helen Campbell et al.
VACCINE (2009)
Vaccination greatly reduces disease, disability, death and inequity worldwide
F. E. Andre et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002
Richard Brooks et al.
CLINICAL INFECTIOUS DISEASES (2006)
Geographic and socioeconomic variation in meningococcal disease: a rural/urban comparison
B Olowokure et al.
JOURNAL OF INFECTION (2006)
An analytical framework for immunization programs in Canada
LJ Erickson et al.
VACCINE (2005)
Inequities in access to medical care in five countries: findings from the 2001 Commonwealth Fund International Health Policy Survey
C Schoen et al.
HEALTH POLICY (2004)
Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001
BJ McCall et al.
INTERNAL MEDICINE JOURNAL (2004)
Geographic correlation between deprivation and risk of meningococcal disease: an ecological study
CJ Williams et al.
BMC PUBLIC HEALTH (2004)
The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics
RS Heyderman et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2004)
Meningococcal disease and social deprivation: a small area geographical study in Gwent, UK
DL Fone et al.
EPIDEMIOLOGY AND INFECTION (2003)
Household crowding a major risk factor for epidemic meningococcal disease in Auckland children
M Baker et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Share Paper
